Cannabis ban for flight crew: when workplace safety overrides legal rights

Can an employer legally stop workers from using a substance that is entirely lawful in their country — not just while they are on the clock, but every hour of every day? In Canada, the answer is now clearly yes, at least in aviation.

A May 2026 arbitration ruling has upheld Air Transat's zero-tolerance cannabis policy for flight attendants, finding the complete off-duty ban reasonable given the extraordinary safety stakes involved in commercial flight. The decision raises a question that cuts across industries and borders: where does workplace safety end and personal privacy begin?

A ruling that goes further than fitness for duty

Quebec arbitrator Nathalie Massicotte dismissed a grievance brought by the Canadian Union of Public Employees (CUPE), Local 4041, which represents Air Transat's cabin crew in Montreal, Quebec. The union had accepted that flight attendants occupy safety-sensitive positions but contested the airline's absolute prohibition on cannabis consumption — arguing that it encroached on employees' private lives and failed to account for the fact that residual effects dissipate within hours of use.

READ MORE: Drug abuse an 'ongoing issue' among US workforce, report finds

The arbitrator rejected that argument. Applying the KVP reasonableness test — a widely used Canadian labour arbitration framework for evaluating workplace policies — and the proportionality standard from the Supreme Court of Canada's 2013 Irving Pulp & Paper decision, Massicotte found that aviation constitutes what she described, in a passage translated from French, as "extreme circumstances" warranting heightened controls.

The science underpinning her decision is striking. Aeromedical physician Anne Thériault testified that no reliable test currently exists to distinguish occasional from chronic cannabis consumers. David Luckow, a toxicology consultant, cited Health Canada data indicating that daily cannabis users face a 25 to 50 per cent risk of addiction. Crucially, Massicotte noted that THC concentrations now reach 90 per cent in vaped concentrates — a far cry from the cannabis products that existed when many jurisdictions first debated workplace drug policies.

Operational context mattered too. The arbitrator cited Air Transat's own data showing 46 in-flight medical incidents in 2024, five of which resulted in passenger deaths, alongside more than 200 disruptive passenger incidents and 161 aborted takeoffs between 2023 and 2025. Aviation and high-risk sector professionals can find further analysis of safety-sensitive role management and drug policy trends at HRD Canada.

What does this mean for HR leaders globally?

The ruling is Canadian, but the policy dilemma it reflects is international. Across jurisdictions where cannabis has been legalised or decriminalised — Canada, parts of the United States, Germany, Thailand, and others — employers in high-risk sectors are grappling with the same tension: employees' right to use a legal product in their personal time versus the employer's duty of care to ensure a workforce that is genuinely fit for duty.

In the United States, the picture is especially complex. Cannabis remains a tested substance under the Department of Transportation's drug testing regulations (49 CFR Part 40) for all DOT safety-sensitive positions — including airline pilots, aircraft maintenance personnel, and transit operators — regardless of state legalisation. A December 2025 Executive Order directed rescheduling of cannabis from Schedule I to Schedule III of the Controlled Substances Act, but, as the US Drug Enforcement Administration has clarified, this does not alter DOT testing rules. The National Transportation Safety Board (NTSB) has separately warned that any weakening of testing authority could compromise safety in aviation, trucking, and rail (NTSB press release, July 2024).

READ MORE: New Oklahoma law forces employers to overhaul marijuana drug testing rules

In Australia, the Civil Aviation Safety Authority (CASA) requires that crew must not operate while impaired by any drug. WorkSafe Western Australia issued updated medicinal cannabis workplace guidance in 2025, reflecting the growing number of employees who hold prescriptions. In the United Kingdom, recreational cannabis remains a Class B controlled substance, making off-duty bans implicit rather than negotiated — but the European Union Aviation Safety Agency (EASA) has identified cannabis as one of the most significant psychoactive substance risks among aircrew alongside alcohol (EASA MESAFE report, 2022).

At the international level, the International Civil Aviation Organization (ICAO) — which sets global standards for aviation safety — prohibits licence holders from exercising their privileges while under the influence of any psychoactive substance. ICAO is currently developing revised guidance on psychoactive substance testing, acknowledging that cannabis and opioids now represent the most commonly used substances in aviation after alcohol. HR professionals managing global workforces across the aviation, transport, or resource sectors can find coverage of international workplace safety developments at HRD Asia.

How aviation stacks up: a global policy snapshot

The table below summarises the regulatory landscape for safety-sensitive aviation roles across key jurisdictions. Policy details reflect publicly available information as of May 2026.

The privacy question employers cannot ignore

Perhaps the most significant aspect of the Air Transat ruling for HR professionals is not the outcome itself but the arbitrator's willingness to acknowledge the privacy cost while still siding with the employer. Massicotte explicitly noted that the policy "encroaches on the right to privacy" — a translated passage from French — but found the intrusion proportionate and justified under section 9.1 of Quebec's Charter of Human Rights and Freedoms.

That reasoning sets a high bar. It signals that courts and arbitrators will not simply defer to an employer's preference for a drug-free workforce. The safety case must be made rigorously — with evidence, operational data, and expert medical testimony — and the policy must be proportionate to the actual risk involved. A blanket off-duty ban for a data entry clerk will not pass the same scrutiny as one for a flight attendant responsible for emergency evacuations at 35,000 feet.

READ MORE: Cannabis users 'disproportionately prone' to workplace absenteeism

The case reinforces several principles for any organisation building or revising drug and alcohol policies: policies must be grounded in evidence, not assumption; expert medical evidence matters; and the definition of a "safety-sensitive" role must be defensible. Those principles apply whether the substance in question is cannabis, opioids, or any other legal product that carries impairment risk. HR teams in Australia and New Zealand navigating similar questions under the Fair Work Act 2009 and Health and Safety at Work Act 2015 respectively can access relevant employment law and workplace safety resources at HRD Australia.

What HR leaders should do now

The Air Transat decision is a timely prompt for HR leaders in any industry to review their current approach to off-duty substance use. Key questions include: Are safety-sensitive roles clearly defined and documented? Is the rationale for any off-duty restriction supported by medical or operational evidence? Have policies been updated to reflect changes in the potency and prevalence of cannabis products since legalisation? And — critically — has legal counsel reviewed the policy in light of the jurisdiction's privacy and human rights framework?

The ruling does not give employers a blank cheque to regulate every aspect of their workforce's private lives. But it does confirm that in industries where a worker's off-duty behaviour can directly affect the safety of others, the scales can tip decisively toward the employer. In the post-legalisation era, that is a precedent HR leaders everywhere should understand.